Akanthos Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Akanthos Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-667,000	Closed	-$180K	–	23
2016 Q3	$180K	Hold	667,000	–	–	0.18%	19
2016 Q2	$160K	Buy	+667,000	New	+$115K	0.15%	14
2016 Q1	–	Sell	-667,000	Closed	-$75K	–	23
2015 Q4	$75K	Hold	667,000	–	–	0.15%	19
2015 Q3	$127K	Buy	667,000 +167,000	+33%	+$56.8K	0.19%	19
2015 Q2	$350K	Hold	500,000	–	–	0.7%	15
2015 Q1	$339K	Hold	500,000	–	–	0.75%	21
2014 Q4	$395K	Hold	500,000	–	–	1.37%	18
2014 Q3	$233K	Hold	500,000	–	–	0.55%	20
2014 Q2	$250K	Hold	500,000	–	–	0.74%	19
2014 Q1	$155K	Hold	500,000	–	–	0.58%	19
2013 Q4	$170K	Hold	500,000	–	–	0.33%	23
2013 Q3	$1.01M	Hold	500,000	–	–	1.29%	17
2013 Q2	$950K	Buy	+500,000	New	+$878K	2.59%	10

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Akanthos Capital Management's GCVRZ Position: Q4 2016 in Review

Akanthos Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 667,000 shares — an estimated $180K sold.

Akanthos Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 13 quarters. The position peaked at $1.01M in Q3 2013. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

Akanthos Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
Akanthos Capital Management sold 667,000 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $180K.
Akanthos Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 13 quarters.
Akanthos Capital Management's Sanofi Contingent Value Rights position peaked at $1.01M in Q3 2013.
120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Akanthos Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.